Kelly Michael Aaron 4
4 · NEOGENOMICS INC · Filed Aug 13, 2024
Insider Transaction Report
Form 4
Kelly Michael Aaron
Director
Transactions
- Exercise/Conversion
Common Stock
2024-08-10+11,336→ 31,755 total - Exercise/Conversion
Restricted Stock Unit
2024-08-10−11,336→ 0 totalExercise: $0.00From: 2024-08-10→ Common Stock (11,336 underlying)
Holdings
- 8,353
Stock Option (Right to Buy)
Exercise: $14.82From: 2024-08-10Exp: 2033-08-10→ Common Stock (8,353 underlying) - 8,672
Stock Option (Right to Buy)
Exercise: $13.71From: 2025-06-01Exp: 2034-06-01→ Common Stock (8,672 underlying) - 12,254
Restricted Stock Unit
Exercise: $0.00From: 2025-06-01→ Common Stock (12,254 underlying) - 2,223
Stock Option (Right to Buy)
Exercise: $37.53From: 2021-05-28Exp: 2027-05-28→ Common Stock (2,223 underlying) - 3,714
Stock Option (Right to Buy)
Exercise: $40.90From: 2022-06-02Exp: 2028-06-02→ Common Stock (3,714 underlying) - 13,882
Stock Option (Right to Buy)
Exercise: $8.10From: 2023-06-10Exp: 2029-06-10→ Common Stock (13,882 underlying)
Footnotes (2)
- [F1]Reflects release of restricted stock units that were previously reported on a Form 4.
- [F2]Once vested, the shares of common stock are not subject to expiration.